MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
171.98%
Quick Ratio
171.68%
Unit: Dollar
Assets Breakdown
    • Current digital assets at fair v...
    • Digital assets at fair value, ne...
    • Deferred tax asset
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid in capital
    • Convertible notes payable
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash
3,482,847
1,616,765
2,237,223
2,975,150
Accounts receivable, net
496,393
594,552
284,261
157,515
Inventory, net
215,237
728,273
1,035,680
1,152,870
Due from vitamedica transition
336,239
304,880
471,380
228,017
Prepaid expenses and other receivables
990,957
1,302,064
1,480,227
350,836
Current digital assets at fair value
-
164,703,917
212,832,396
49,913,655
Assets available for sale - building
-
-
-
0
Current digital assets at fair value
114,942,784
-
-
-
Purchase price receivable - vitamedica
1,340,000
2,000,000
2,000,000
2,000,000
Purchase price receivable - e-core
-
-
-
0
Total current assets
121,804,457
171,250,451
220,341,167
56,778,043
Property and equipment, net
241,215
543,246
1,931,498
2,052,573
Intangible assets, net
855,543
874,733
143,923
163,113
Goodwill
673,854
673,854
848,854
848,854
Deferred tax asset
5,948,858
5,948,858
5,948,858
5,948,858
Investment in digital company
-
-
750,000
-
Digital assets at fair value, net of current
69,960,104
90,998,464
187,993,435
56,083,525
Other assets
178,589
218,710
200,690
192,123
Right-of-use asset, net
711,063
636,449
1,569,742
1,739,755
Total other assets
-
99,894,314
199,387,000
67,028,801
Total noncurrent assets
78,569,226
-
-
-
Total assets
200,373,683
271,144,765
419,728,167
123,806,844
Accounts payable
288,722
665,840
2,184,897
-
Accrued compensation
4,506,613
3,111,115
3,176,969
-
Deferred revenue
2,324
47,287
51,347
-
Accrued liabilities
2,166,822
1,964,281
947,076
-
Accrued interest
2,268,473
2,902,942
1,545,481
-
Acquisition payable
260,652
260,652
260,652
-
Current portion of promissory notes
0
560,000
560,000
-
Short-term treasury debt
57,295,723
62,695,723
50,000,000
-
Current portion of cygnet subsidiary notes payable
3,694,721
5,380,910
5,380,910
-
Current portion of operating lease payable
339,669
263,672
521,702
-
Total current liabilities
70,823,719
77,852,422
64,629,034
-
Operating lease payable, net of current portion
437,077
460,134
1,145,439
-
Convertible notes payable
181,031,073
144,115,480
143,161,862
-
Total long-term liabilities
181,468,150
144,575,614
144,307,301
-
Preferred stock, 0.00001 par value, 10,000,000 shares authorized, and 150,000 shares issued and outstanding
2
2
2
-
Common stock, 0.00001 par value, 1,000,000,000 shares authorized, 66,895,799 and 38,270,571 shares issued, as of march 31, 2026 and june 30, 2025, respectively
669
632
589
-
Treasury stock, 416,226 and 0, as of december 31, 2025 and june 30, 2025, respectively
-
799,277
-
-
Additional paid in capital
230,145,603
222,236,002
204,586,941
-
Accumulated deficit
-282,064,460
-172,720,630
6,204,300
-
Total stockholders' equity
-51,918,186
48,716,729
210,791,832
-
Total liabilities and stockholders' equity
200,373,683
271,144,765
419,728,167
123,806,844
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Current digital assetsat fair value$114,942,784 Cash$3,482,847 Purchase pricereceivable - vitamedica$1,340,000 Prepaid expenses andother receivables$990,957 Accounts receivable, net$496,393 Due from vitamedicatransition$336,239 Inventory, net$215,237 Digital assets at fairvalue, net of current$69,960,104 Deferred tax asset$5,948,858 Intangible assets, net$855,543 Right-of-use asset, net$711,063 Goodwill$673,854 Property and equipment,net$241,215 Other assets$178,589 Total current assets$121,804,457 Total noncurrentassets$78,569,226 Total assets$200,373,683 Accumulated deficit-$282,064,460 Total liabilities andstockholders' equity$200,373,683 Total stockholders'equity-$51,918,186 Additional paid in capital$230,145,603 Common stock, 0.00001par value,...$669 Preferred stock, 0.00001par value,...$2 Total long-termliabilities$181,468,150 Total currentliabilities$70,823,719 Convertible notes payable$181,031,073 Operating lease payable,net of current...$437,077 Short-term treasury debt$57,295,723 Accrued compensation$4,506,613 Current portion ofcygnet subsidiary...$3,694,721 Accrued interest$2,268,473 Accrued liabilities$2,166,822 Current portion ofoperating lease payable$339,669 Accounts payable$288,722 Acquisition payable$260,652 Deferred revenue$2,324

UPEXI, INC. (UPXI)

UPEXI, INC. (UPXI)